[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$gsks
GSK's dementia drug trial fails, sparking concern and potentially impacting biotech stocks with an upcoming FDA decision on Blenrep.
About $gsks
GSK is a pharmaceutical company.
Insights #
- $gsks mentions hit X which is XXX% higher than it's daily average.
- $gsks creators is up XXXXXX% from the previous year.
- $gsks engagements is up XXXXXX% from the previous week.
- $gsks mentions is up XXXXXX% from the previous year.
- $gsks posts created is up XXX% from the previous week.
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXX
1 Week: XXXXX +377%
1 Month: XXXXX -XX%
6 Months: XXXXXX +243%
1 Year: XXXXXX +1,852%
1-Year High: XXXXXX on 2025-07-17
1-Year Low: X on 2024-12-28
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Week: X +100%
1 Month: XX +117%
6 Months: XX +42%
1 Year: XX +422%
1-Year High: X on 2024-12-10
1-Year Low: X on 2024-10-30
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $gsks in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Week: X +75%
1 Month: XX +100%
6 Months: XX +55%
1 Year: XX +257%
1-Year High: X on 2025-10-03
1-Year Low: X on 2024-10-30
The most influential creators that mention $gsks in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @ByMadeleineA | X | XXXXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
6 Months: XX% -XX%
1-Year High: XXX% on 2024-12-06
1-Year Low: XX% on 2025-07-17
Most Supportive Themes
- FDA Decision on Blenrep: (33%) The FDA's decision on GSK's Blenrep drug is a significant event that could impact biotech stocks.
- Dementia Drug Trial: (33%) GSK's dementia drug has failed a trial, raising concerns about its efficacy and future development.
Most Critical Themes
- Biomarker Endpoint vs. Clinical Benefit: (33%) A recent trial failure highlights the challenge of relying on biomarker endpoints without clear clinical benefit.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | X | X% | X | X% | XX | X% |
| Total | XX | X% | X | X% | X | X% |
Top topics mentioned In the posts about $gsks in the last XX hours
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@RaajitRampal @clinadvances @doctorpemm @TaniaJain11 @Medscape @MKremyanskaya @doclucchesi @harrisoncn1 @VasNarasimhan @antengene @EricTokat @IcahnMountSinai @HealthTree @traviscooper93 @mpnadvocacy @GabyHobbs @Stemline @Blood_Cancers @SocietyofHemOnc @mpdrc @mlieducation @MDmasarova @JamesPharma $GSK's momelotinib sales slowing down () in Q3 $146m vs. Q2 $138m vs. Q1 $112m $KPTI /287"
X Link @kinatsofrim 2025-10-29T15:48Z XXX followers, XXX engagements
"As for $GSK's IDRx buy the second-line StrateGIST X trial of GSK6042981 has just been unveiled and a first-line trial is to start in 2026"
X Link @ByMadeleineA 2025-10-29T10:02Z 8120 followers, 1046 engagements
"FDA has posted the approval letter for $GSK's Blemrep showing details of the REMS and postmarket study requirements"
X Link @RxRegA 2025-10-27T20:08Z 5853 followers, XXX engagements
"On $ALEC and $GSKs dementia drug fail which met a biomarker endpoint but failed to slow disease progression @cngarabedian says This speaks to the challenge of accepting biomarkers without correlative or concordance on the clinical benefit. So this is one where they say hey it did what we said it was going to do and we're seeing it on the biomarker but we just didn't see the clinical benefit play through $ALEC was one of these companies that is using a novel technology that binds to a unique region of the transferrin receptor. There have been a number of companies that people have been excited"
X Link @BiotechCH 2025-10-24T17:05Z 15.2K followers, 1177 engagements